Abstract
compositions showing rapid apatite formation are presented, superior to 45S5 Bioglass® which was tested under identical conditions for comparison.

Introduction
Bioactive glasses and ceramics have been important for mineralised tissue regeneration in orthopaedic applications for over 30 years [1] . However, recently these materials are finding usage in products such as toothpaste as reminerialising agents [2] . The toothpaste Sensishield marketed in the EU by Periproducts contains Novamin (45S5 Bioglass®) as the active ingredient and there is also a toothpaste on the market which contains a zinc substituted hydroxyapatite [3] . L'Oreal also have a patent [4] for Bioglass as an additive to products for relaxing / straightening hair. This opens up the possibility for bioactive glasses to be used in a variety of consumer products.
This study reports the bioactivity of two series of glasses of which structure and properties have been previously reported [5, 6] . In series I phosphate was added to the glass, replacing SiO 2 and the Ca to Na ratio was kept constant. In series II, it was assumed phosphate did not enter the silicate network, but formed a separate orthophosphate phase and sufficient Ca and Na was added to ensure charge neutrality in the PO 4 3-complex formed. As the previous study showed, the formation of this type of phosphate structure resulted in removal of network modifiers in series I, polymerising the silicate network and resulting in an increase in Q 3 structural units and a reduction in Q 2 .
In series II, as sufficient modifier was added to charge balance the orthophosphate species, no change in the silicate structure was seen by solid state NMR; effectively the silicate network remained Q 2 , [Si n O 3n ] 2n-chains of infinite molar mass.
Simulated body fluid (SBF) has been used in vitro in a large number of studies to predict in vivo bioactivity in particular in glass-ceramic systems to assess the formation of hydroxyl-carbonated-apatite at the surface of the material (HCAp). The formation of
HCAp after a reasonable time period in SBF is a good indicator that the material will form a bond and integrate well with bone in vivo. Although SBF experiments should be complemented by cell studies, followed by animal and human trials, SBF data can be used to screen out materials for these expensive and possibly unnecessary studies. The glasses studied here are modifications of the original 45S5 Bioglass® composition [1] and glasses studied by Elgayar et al. [7] , with phosphate added to investigate the effect on bioactivity. The two most obvious negative effects in vivo might be degradation of the phosphate component of the glass producing an excessively acidic pH and hence cytotoxicity and pyrophosphate (Q 1 phosphate) species producing wide macrophagic activation [8] . It is know that all the glasses in this study contain a separate orthophosphate (Q 0 phosphate) phase. In the compositions studied the degradation and production of acidic pH caused by phosphate would be buffered by the large amount of basic ions (Na and Ca) in the glass and should not result in an acidic pH as seen in polyphosphate glasses [9] . Acidic pH conditions is not desirable for the formation of crystalline apatite. We would not expect the production of pyrophosphate species either as all but one of the glasses studied have a network connectivity (NC) less than 2.5.
Typically soda-lime-phosphosilicate glasses with NC > 2.5 contain some phosphate in a Q 1 configuration [7, 10] .
Experimental
The processing of these glasses have been previously reported [5, 6] . Compositions can be found in table (1) also with network connectivity values assuming phosphate enters the glass network (NC) and that a separate orthophosphate phase is formed (NC').
SBF
Simulated body fluid was prepared according to Kokubo and Takadama [11] . Glass particles of diameter <38µm were immersed in this solution in sealed containers for up to 21 days and were mechanically agitated at 60 rpm using an incubator set to 37°C. At various time points the samples were filtered and dried to constant weight for analysis by XRD and FTIR.
XRD
A Phillips powder diffractometer with a copper (Cu K α ) X-ray source (Philips PW 1700 series diffractometer, Philips, Endhoven, NL) was used to characterise the glass samples.
The powdered samples were recorded between 10 and 60 2 at a scan speed of 0.04.s -1 .
For crystallite size analysis high resolution scans of the (002) apatite peak were take between 24 and 28 2 for a step size of 0.01, collecting data on each step for 5s. Peak analysis was performed using SciDAVis 0.1.3 software.
FTIR
FTIR spectra were obtained using a Bruker IFS 28 Fourier transform infrared spectrometer in the mid-IR range of 550 to 2000 cm -1 with a resolution of 0.2 cm -1 .
Powdered samples were pressed into pellets with KBr. Peak analysis was performed using SciDAVis 0.1.3 software.
Results and discussion
SBF
Fig
. (1) and (2) shows the variation in pH with time for series I and II glasses respectively after immersion in SBF. As a general trend the SBF becomes more basic with time. This is to be expected as more sodium and calcium ions are released. The solution also shifts towards acidity as the phosphate content of the glasses is increased in both series. This can be explained by the release of more phosphate from the glass which will buffer the alkalinity caused by the sodium and calcium ions. This decrease in pH is advantageous for bioactivity as a pH of 7.2 is optimal in physiological fluid for apatite deposition [8] . corresponding to the (002) and (211) and reflections [12, 13] . The region containing the (211) peak (30 to 35) also contains a number of other features, namely the (112), (300) and (202) reflections [12, 13] . However due to the noise and degree of peak overlap, these lines could not be used for crystallite size analysis. The (002) peak was used for this purpose. Apatite formation can be clearly seen after 16 hours. Fig. (5) shows the crystallite size obtained from the peak width and position of the 002 peak using the Scherrer equation [14] . After 21 days there is no real variation in the apatite crystallite size. For series II there is possibly a decrease in crystal size with phosphate content, but the variation over the series is less than the error of the peak fitting.
XRD
FTIR
Fig. (6) and (7) show FTIR spectra of selected glasses from both series immersed in SBF for up to 21 days. For the glasses containing phosphate, in the 500 to 600 cm -1 region there is a broad feature corresponding to the P-O bending mode and also a Si-O-Si bending vibration in this region [13, [15] [16] [17] . Around 720 cm -1 in the glass spectra is the band due to Si-O bending vibrations [18, 19] . 
General comments
All glasses showed formation of apatite in the 21day period tested in SBF. Table (2) summarises the time in which the characteristic splitting of the FTIR P-O bending mode at around 550 cm -1 was seen indicating crystalline apatite formation. As a general trend, apatite formation is faster as the phosphate content is increased in the parent glass; even in series I which shows an increase in network connectivity with increasing P 2 O 5 . This indicates that phosphate content is more important than network connectivity of the silicate phase for bioactivity in the range of compositions studied as long as the phosphate is present as Q 0 species [5, 6] . The glass ICSW4, containing the highest phosphate content in both series does not fit in with the trend shown in table (2) . It is know from previous studies that this sample was partially crystalline [5, 6] which would account for the slower rate of apatite formation compared to the other glasses.
The area of the P-O bending mode (also known as the v 4 phosphate region) can be seen to linearly correlate with the area of the (002) Bragg reflection from XRD as presented in fig. (9) . The areas of these features after 21 days in SBF both increase with phosphate in the parent glass. This indicates that as a general trend, as more phosphate is added to the glasses, more apatite forms which suggests the phosphate content is more important in these two series of glasses than NC for mineralisation even though the network connectivity is increasing in series II and fixed in series II. Also as fig. (5) shows, the size of the apatite crystals are not varying with phosphate content in the parent glass after 21 days in SBF, but the amount of crystals clearly increases due to the increase in the areas of the features in the XRD and FTIR data associated with HCAp crystallinity. Fig. (10) compares the bioactivity of glass ICSW9 against 45S5 Bioglass® from FTIR spectra taken on glass powders of identical particle sizes exposed to the same SBF conditions. It can clearly be seen that after 1 day in SBF the apatite formed on the ICSW9 glass is highly crystalline with intense, narrow, split peaks in the 550 cm -1 region, whereas the phosphate peak can hardly be resolved from the background in 45S5. This unequivocally shows the glasses studied here show superior bioactivity and potential as hard tissue remineralising agents compared to 45S5 Bioglass®
The increased apatite formation could be a result of phase morphology. Pyrex is comprised of sodium borate rich drops in a silica rich matrix. The drops at the glass surface degrade when exposed to corrosive media, however those in the bulk are not affected. Vycor® is another phase separated borosilicate glass. However the borate phase is interconnected and the glass can be etched to form a porous structure. The high phosphate content glasses presented in this study which show increased apatite deposition may exhibit an interconnected orthophosphate morphology resulting in continuous phosphate leaching on exposure to SBF and enhanced apatite formation kinetics. This may be explained by a rapid increase in the surface area of glass exposed to solution in the initial stages of exposure.
Conclusions
Compositions are typically designed in weight percentages in the patent literature and also, surprisingly, in the scientific literature. This study avoids that approach as it is difficult to correlate changes in composition with changes in properties. The glasses presented here were designed on a molecular percentage basis. For example in the studies by Gorustovich et al. [25, 26] , the authors substituted calcium oxide with strontium oxide on a weight percentage basis. No difference was seen in the two sets of samples in vivo.
However, as strontium has a much higher relative atomic mass than calcium, replacing the weight of calcium in the glass with strontium would result in an increase in silica content. This would increase the network connectivity (NC [5, 6] ) of the glass, slow dissolution and reduce bioactivity. The beneficial properties of adding the strontium to the glass [27] , namely speeding dissolution, decreasing osteoblast differentiation and function whilst decreasing osteoclasts, would be cancelled out by the increase in NC.
Therefore it is no surprise no real difference was seen in the calcium bioactive glass compared to the strontium sample in the study by Gorustovich et al.
In summary, two series of glasses were studied to examine both the effect of network connectivity of the silicate phase and phosphate content on bioactivity. All glasses studied produced a hydroxyl-carbonated-apatite layer on immersion in SBF for up to 21
days. The formation of this layer occurred more rapidly as the phosphate content increased for both series. This is a clear indication that in the compositional ranges studied here, phosphate content is a more important variable than the connectivity of the silicate network or an overriding factor in a process where NC and phosphate dissolution compete. The bioactivity of soda-lime-phosphosilicate glasses can be improved significantly by designing compositions with a good understanding of glass structure. Tables   Table (1 
